Gilder Gagnon Howe & CO LLC Acadia Pharmaceuticals Inc Transaction History

Gilder Gagnon Howe & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 31, 2018	SELL	$15.07 - $22.34 $90,751 - $134,531	-6,022 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$22.47 - $32.33 $2.4 Million - $3.45 Million	-106,604 Reduced 94.65%	6,022 $135,000
Q4 2017 Jan 31, 2018	SELL	$26.84 - $39.14 $283,027 - $412,731	-10,545 Reduced 8.56%	112,626 $3.39 Million
Q3 2017 Nov 06, 2017	BUY	$29.49 - $38.37 $3.63 Million - $4.73 Million	123,171	123,171 $4.64 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.